Press

 

Media presence is a key part of making society aware of developments in biotechnology and its benefits.This is where we post all our press releases. If you are a journalist interested in learning more about the biotechnology sector, contact Ángel Luis Jiménez, our Communication Director: ajimenez@asebio.com 

Search engine
Participantes en la clausura de BIOSPAIN 2026
BIOSPAIN 2026 closes in Bilbao, strengthening its position as a meeting point for BioRegions and a hub for the major debates shaping biotechnology
BioSpain
  • The congress brought together more than 1,900 attendees from nearly 900 organisations across 32 countries, as well as 95 investors representing 50 national and international investment organisations.
  • BIOSPAIN 2026 concludes its latest edition with more than 4,000 one-to-one meetings held.
  • Barcelona will host BIOSPAIN 2027, with Mexico as Guest Country.
AseBio
Bloque de Bioeconomía
Biotechnology drives new solutions to advance towards a more sustainable economy and address major health and production challenges
International · BioSpain
  • HIPRA, SID and the Xunta de Galicia highlight at BIOSPAIN 2026 the role of prevention, collaboration and innovation ecosystems in transforming scientific knowledge into solutions with real impact.
  • Collaboration between science, industry and public authorities is key to accelerating technology transfer to the market.
AseBio
Salud_Biospain_2026
BIOSPAIN 2026 explores the potential of new technologies to advance personalised medicine
International · BioSpain
  • Smart biomaterials, advanced drug delivery systems and advanced therapies are opening up new possibilities for addressing complex diseases and tailoring treatments to the characteristics of each patient.
  • Collaboration between biotechnology companies, research centres, hospitals, the pharmaceutical industry and health authorities has been identified as a key factor in accelerating the transfer of biomedical innovation.
AseBio
NdP de Inversión
From scientific knowledge to market: company creation, financing and technology transfer as key drivers of biotech innovation
International · BioSpain
  • BIOSPAIN 2026 focuses on the creation and growth of startups and spin-offs, access to financing and technology transfer as essential elements for turning scientific knowledge into solutions capable of reaching the market. 
  • Experts highlight the importance of an ecosystem capable of supporting companies from their earliest stages, combining science, talent, financing and an international outlook to foster their growth and expansion into new markets. 
AseBio
Inaguracion-BIOSPAIN-2026
BIOSPAIN 2026 kicks off in Bilbao, placing the city at the heart of European biotechnology and its major strategic debates
International · BioSpain
  • The Bilbao Exhibition Centre (BEC) will host BIOSPAIN 2026 from 29 September to 1 October, organised by AseBio in collaboration with the Provincial Council of Bizkaia, the Basque Government and the Basque Health Cluster.
  • The opening ceremony was attended by AseBio President Cristina Nadal; Ainara Basurko, Provincial Councillor for Economic Promotion at the Provincial Council of Bizkaia; Jaione Ganzarain, Deputy Minister for Technology, Innovation and Digital Transformation of the Basque Government; and Juan Cruz Cigudosa, Secretary of State for Science, Innovation and Universities.
  • Ten years after it was last held in the Basque Country, BIOSPAIN returns to one of Spain’s most established life sciences and healthcare ecosystems, with a growing European profile.
  • The United Kingdom will be the Guest Nation at BIOSPAIN 2026, strengthening the international dimension of the event and the links between two of Europe’s most dynamic biotechnology ecosystems.
AseBio
Día Mundial del Alzheimer
Biomarkers and artificial intelligence open new avenues for anticipating Alzheimer’s progression
Healthcare · In vitro diagnostics · Personalized medicine
  • In Spain, nearly one million people were living with dementia in 2025, according to estimates from Alzheimer Europe, with Alzheimer’s disease accounting for between 60% and 70% of cases.
  • Biotechnology, new biomarkers and artificial intelligence are making it possible to integrate increasing amounts of information to characterise patients and move towards earlier and more personalised approaches.
  • To mark World Alzheimer’s Day, AseBio explores these advances together with its member ADmit Therapeutics, which has developed MAP-AD®, a test designed to predict progression from mild cognitive impairment to Alzheimer’s disease dementia.
AseBio
Siete asociaciones presentan el informe técnico que respalda la necesidad de revisar la aplicación de la Directiva de Aguas Residuales
Seven organisations present a technical report supporting the need to review the implementation of the Urban Wastewater Treatment Directive
Healthcare · Industrial biotechnology · Bioeconomy · Circular economy
  • The report is presented at a time of growing European debate over the implementation of the Directive, following the European Parliament’s call for a new assessment and the recent conclusions of the Advocate General of the Court of Justice of the European Union, which question aspects of the allocation of responsibilities to the pharmaceutical and cosmetics sectors.
  • The associations share the environmental objectives of the Directive but call for a prudent and legally robust transposition based on proportionality and sound scientific evidence.
AseBio
Realizando pruebas en el laboratorio
Sepsis causes 11 million deaths every year, while new biomarkers are paving the way for a more precise approach
Healthcare · In vitro diagnostics · Personalized medicine
  • In Spain, around 50,000 people are affected by sepsis each year and approximately 17,000 die, highlighting the significant impact of this medical emergency.
  • Biotechnology is driving the development of new biomarkers and diagnostic tools to detect the risk of deterioration earlier, understand each patient’s immune response and advance towards precision medicine.
  • On World Sepsis Day, AseBio brings together the perspectives of clinical experts, researchers and our partner Viva In Vitro Diagnostics to analyse the main current challenges and the future of sepsis management.
AseBio
Agricultor sosteniendo una planta en un campo de cultivo
Biotechnology opens up new pathways to regenerate soils and increase crop resilience
Climate change · Agrifood · Food & feed · Agriculture
  • Agriculture is facing increasing pressure on soil and water resources, with more than 60% of human-induced land degradation occurring on agricultural land.
  • Biotechnology innovation has a key role to play in advancing towards more sustainable and regenerative agriculture, capable of restoring soil health and fertility, improving resource management and increasing crop resilience.
  • On the occasion of World Agriculture Day, we spoke with our member Phoenix Biosolutions, which develops biotechnology solutions based on microalgae and biostimulants, to explore how these innovations can contribute to more sustainable, regenerative and resilient agriculture.
AseBio